IDiyas

For the Inventor, By the Inventor

Burlingame, CA, United States of America

Douglas T Ross

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 3.9

ph-index = 5

Forward Citations = 68(Granted Patents)


Location History:

  • San Francisco, CA (US) (2006)
  • Huntsville, AL (US) (2011)
  • Birmingham, AL (US) (2013)
  • Burlingame, CA (US) (2009 - 2015)

Company Filing History:

goldMedal5 out of 5 
 
Applied Genomics, Inc.
 patents
silverMedal5 out of 5 
 
Clarient Diagnostic Services, Inc.
 patents
bronzeMedal2 out of 5,307 
 
Leland Stanford Junior University
 patents
4. 2 out of 581 
 
The Uab Research Foundation
 patents
where one patent can have more than one assignee

Years Active: 2006-2015

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents
1. 9005900 - TLE3 as a marker for chemotherapy (2015-04-14),
2. 8785156 - TLE3 as a marker for chemotherapy (2014-07-22),
3. 8697373 - Reagents and methods for use in cancer diagnosis, classification and therapy (2014-04-15),
4. 8520024 - Virtual interactive presence systems and methods (2013-08-27),
5. 8440410 - Reagents and methods for use in cancer diagnosis, classification and therapy (2013-05-14),
6. 8399622 - Reagents and methods for use in cancer diagnosis, classification and therapy (2013-03-19),
7. 7960125 - Identification of thymically derived CD4 T cells by protein tyrosine kinase 7 expression (2011-06-14),
8. 7816084 - TLE3 as a marker for chemotherapy (2010-10-19),
9. 7811774 - Reagents and methods for use in cancer diagnosis, classification and therapy (2010-10-12),
10. 7754431 - TLE3 as a marker for chemotherapy (2010-07-13),
11. 7504225 - Reagents and methods for use in cancer diagnosis, classification and therapy (2009-03-17),
12. 7118853 - Methods of classifying, diagnosing, stratifying and treating cancer patients and their tumors (2006-10-10),

Title: Douglas T. Ross: Innovator in Cancer Treatment

Introduction

Douglas T. Ross is a prominent inventor based in Burlingame, CA, known for his significant contributions to cancer treatment through innovative research and patented technologies. With a total of 12 patents to his name, Ross has made strides in the medical field, particularly in the area of chemotherapy.

Latest Patents

Among his latest patents, Ross has developed methods utilizing TLE3 as a marker for predicting the likelihood that a patient's cancer will respond to chemotherapy. He has also created methods for selecting appropriate chemotherapy treatments based on TLE3 markers. These advancements hold promise for improving patient outcomes in cancer therapy.

Career Highlights

Throughout his career, Douglas T. Ross has worked with notable companies such as Applied Genomics, Inc. and Clarient Diagnostic Services, Inc. His work in these organizations has been instrumental in advancing cancer diagnostics and treatment methodologies.

Collaborations

Ross has collaborated with esteemed colleagues, including Brian Z. Ring and Robert S. Seitz, contributing to a rich exchange of ideas and innovations in the field of cancer research.

Conclusion

Douglas T. Ross continues to be a key figure in the fight against cancer, leveraging his inventions to enhance treatment options and improve patient care. His work exemplifies the impact of innovation in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…